Danish Biotech Stock News

DSV recently reached a major sustainability milestone by operating over 400 battery electric trucks across its European network, making it one of the largest electric heavy goods vehicle fleets in Europe. This advancement signals meaningful progress in freight decarbonisation, showcasing how DSV’s investments in route planning and charging infrastructure can deliver zero-emission shipments without sacrificing reliability. We'll explore how DSV’s large-scale rollout of electric trucks may...

Pandora A/S recently reported third-quarter 2025 earnings, with sales increasing to DKK 6,269 million and net income decreasing to DKK 489 million compared to the prior year, while also maintaining its 2025 guidance of 7-8% organic growth and an EBIT margin of around 24%. While quarterly profits softened, Pandora's confirmation of its full-year outlook highlights management's continued confidence in the company's growth and profitability expectations. We'll explore how the reaffirmed 2025...

Zealand Pharma reported its third quarter 2025 results, announcing sales of DKK49.57 million and a quarterly net loss of DKK404.23 million, while nine-month sales reached DKK9.15 billion with net income of DKK6.83 billion. This rapidly shifting financial picture shows a swing from net loss to substantial net income over the nine-month period, underlining the impact of recent commercial developments. We'll now consider how Zealand's dramatic year-to-date earnings turnaround may influence the...

Earlier this month, Jyske Bank reported strong Q3 2025 results, surpassing earnings and revenue forecasts and raising its full-year net profit guidance. An interesting insight is that the bank’s outlook benefited from stable net interest income, exceptionally low loan losses, and continued growth in its customer base. We'll now explore how Jyske Bank’s upgraded profit guidance and resilient credit quality could influence its long-term investment narrative. AI is about to change healthcare...

It's been a good week for Scandinavian Tobacco Group A/S ( CPH:STG ) shareholders, because the company has just...

Vestas Wind Systems A/S ( CPH:VWS ) recently posted some strong earnings, and the market responded positively. Our...

As you might know, H+H International A/S ( CPH:HH ) recently reported its third-quarter numbers. The result was fairly...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...

Most readers would already be aware that NKT's (CPH:NKT) stock increased significantly by 21% over the past three...

Recent company filings reveal that several top insiders at Gubra (CPSE:GUBRA), including the co-founder, CEO, and chairman, have bought substantial amounts of company shares. Insider buying like this often sparks fresh interest from investors who are looking for signals about a company’s prospects. See our latest analysis for Gubra. It has been a volatile year for Gubra, with a 1-year total shareholder return of -24.78% reflecting ongoing challenges. However, the recent insider buying comes...

Earlier this week, Tryg Forsikring A/S completed the successful pricing and subscription of new Perpetual Restricted Tier 1 Capital Notes, raising NOK300 million and SEK700 million, with demand very large and mostly placed with asset managers in the Nordic region. This transaction reflects investor confidence and will allow Tryg to proactively manage its capital structure by repurchasing outstanding notes at a premium, contingent on the full settlement of the new issue. We'll explore how...

Ørsted A/S recently reported third quarter 2025 earnings, revealing sales of DKK 12,270 million and a net loss of DKK 1,789 million, compared to net income of DKK 5,114 million a year earlier. This unexpected swing from profit to loss in the quarter stands out, especially as nine-month results remained stable year-over-year. We’ll explore how Ørsted’s shift to a quarterly loss, despite steady nine-month performance, shapes discussion around the company’s outlook. Explore 27 top quantum...

H. Lundbeck (CPSE:HLUN B) attracted fresh attention from investors following its latest quarterly update. The company not only delivered stronger sales and earnings, but also raised its full-year revenue guidance for 2025. See our latest analysis for H. Lundbeck. After a steady stretch earlier in the year, H. Lundbeck's share price has picked up momentum, rising 16.7% over the past three months as investors reacted positively to its upgraded revenue outlook and stronger recent results...

GN Store Nord (CPSE:GN) just released its latest quarterly and nine-month earnings, offering investors a look at some challenging shifts. The company reported lower sales and a sharp drop in net income compared to last year, raising questions about its operational momentum. See our latest analysis for GN Store Nord. After the earnings announcement highlighted a slide in sales and net income, GN Store Nord’s share price has been grappling with renewed skepticism, even as the company steps up...

While ISS A/S ( CPH:ISS ) might not have the largest market cap around , it saw a double-digit share price rise of over...

Ambu A/S recently reported annual sales of DKK 6,037 million and net income of DKK 609 million for the year ended September 30, 2025, alongside announcing a DKK 0.41 per share annual dividend payable in December 2025. These results reflect much higher profitability and earnings per share compared to the prior year, underpinned by both revenue growth and improved operating margins. With Ambu's updated financial guidance projecting double-digit organic growth and higher profit margins, we'll...

As the European markets face pressures from concerns over artificial intelligence stock valuations, major indices like the STOXX Europe 600 and Germany's DAX have recently seen declines. In this environment, investors may find opportunities in value stocks that are trading at estimated discounts, offering potential resilience amidst market fluctuations.

Wondering if Novo Nordisk stock is trading at a bargain or set for a pullback? You are not alone. Valuation is a top focus for investors trying to spot the next opportunity. The share price has shown real movement recently, climbing 6.6% this past week. However, it is still down 14.1% in the last month and down a hefty 56.3% over the past year. Investors are weighing fresh headlines, with increased scrutiny on the competitive landscape for GLP-1 drugs and new...

The market rallied behind Trifork Group AG's ( CPH:TRIFOR ) stock, leading do a rise in the share price after its...

NTG Nordic Transport Group A/S ( CPH:NTG ) came out with its third-quarter results last week, and we wanted to see how...

Netcompany Group A/S released its third quarter and nine-month 2025 earnings, reporting a DKK 67.9 million net loss for the quarter despite higher sales, and subsequently revised its full-year guidance, projecting organic revenue growth between 6% and 8%, narrowing the previous range. This combination of declining profitability alongside raised guidance floors suggests management expects stabilizing revenue performance but is contending with increased costs or margin challenges. To assess...

Jyske Bank (CPSE:JYSK) issued its Q3 2025 report, showing earnings and revenue well ahead of expectations. The bank also improved its full-year net profit outlook, which is likely to catch investor attention. See our latest analysis for Jyske Bank. Jyske Bank’s upbeat Q3 report, improved outlook, and hints at further industry moves have certainly kept investors interested. The stock’s share price has soared 54.3% year-to-date, with a 71.4% total shareholder return over the past year...

ALK-Abelló (CPSE:ALK B) has seen its stock price edge higher recently, gaining almost 1% over the past week and rising 12% in the past 3 months. Investors appear to be weighing the company’s recent financial momentum and future prospects, while trading volumes remain steady. See our latest analysis for ALK-Abelló. While ALK-Abelló’s recent share price strength has turned heads, the bigger story is its sustained momentum, with a year-to-date share price return of nearly 27% and an impressive...

On November 11, 2025, Rockwool A/S updated its full-year 2025 guidance, lowering its expected EBIT margin to a range of 14% to 15%, compared to the previous outlook of below 16%, while maintaining its revenue forecast at last year's level. This adjustment highlights a more measured profit outlook even as the company anticipates steady sales, reflecting current operating cost pressures. We'll explore how Rockwool's revised EBIT margin outlook may influence the company's longer-term investment...